Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
BLK enters its October 14 earnings report at $1,079.42, down 3.8% over the past month but clawing back 1.1% this week, with the Street actively repricing targets in both directions ahead of the print.
The most active story this week is analyst positioning, and it is not uniform. JP Morgan lifted its Overweight target to $1,435 from $1,364 on October 6, a meaningful upward revision. UBS and Barclays both trimmed targets on October 7, to $1,277 and $1,420 respectively, while keeping Buy and Overweight ratings intact. Wells Fargo initiated coverage with Overweight at $1,245 earlier in the week. The consensus mean target of $1,315 sits roughly 22% above the current price, and the analyst recommendation factor ranks in the 97th percentile of the ORTEX universe, indicating the Street's aggregate conviction in BLK remains unusually high even as individual targets drift. Morgan Stanley trimmed to $1,479 in late September and Evercore ISI cut to $1,207 earlier in the month, so the direction of travel on targets has been broadly lower, but no major firm has dropped its positive rating.
Options positioning adds a different dimension. BLK's put/call ratio has fallen to 0.71, well below its 20-day average of 0.79 and near the 52-week low of 0.70. That reading, 1.2 standard deviations below the mean, reflects call-heavy positioning rather than defensive hedging. Into the week of earnings, options traders are leaning bullish rather than cautious, a contrast to the mixed analyst target trajectory.
Short positioning is not a primary angle here. BLK's short interest amounts to 1.3% of free float, with only a marginal change over the past week. The borrow market is extremely loose: availability of shares to borrow is effectively unconstrained, with 154 million shares available against roughly 2 million short. Cost to borrow edged up 17% on the week but remains negligible at 0.26%. There is no evidence of meaningful short-side pressure, and the ORTEX short score of 31.6 places BLK comfortably in the lower half of bearish conviction rankings.
The valuation picture adds nuance to the bull case. BLK trades at a price-to-earnings ratio of approximately 17.4x, with EV/EBITDA near 11.5x. Forward earnings estimates have been rising sharply: the EPS 12-month forward year-on-year increase factor ranks in the 98th percentile, pointing to substantial upward revisions to near-term profit forecasts. The 90-day EPS momentum rank of 75 reinforces that direction. On the bear side, the company's own case identifies G&A expenses growing 13.3% in 2025 and operating margins revised down to 43.9% and 45.2% for 2025 and 2026. At a 17x multiple, investors are not paying a premium, but the margin revision story will be a central question on October 14.
Institutional ownership is steady and concentrated. Vanguard Capital Management holds 6.5% of shares, and State Street added 136,020 shares in the most recent reported quarter. Wellington Management added 850,406 shares as of its July filing, a more material increment. The October 14 print is where the cost structure debate meets the AUM growth story, and whether organic fee growth can absorb the compensation headwinds is the number the Street will focus on first.
See the live data behind this article on ORTEX.
Open BLK on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
